{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:01:04Z","timestamp":1790834464612,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Almost a century after the discovery of penicillin, the antimicrobial resistance (AMR) crisis has become as much a failure of global governance as a biomedical challenge. Published Global Burden of Disease estimates for 2000\u20132021 show a persistent geographic hierarchy of mortality, a pattern consistent with AMR burden being embedded in health system capacity rather than due to pathogen evolution alone. Furthermore, the for-profit pharmaceutical model remains structurally misaligned with the clinical necessity of restricted antibiotic use. This Perspective argues that the next phase of AMR mitigation must pivot from a discovery-dominated paradigm to an integrated preparedness model in which innovation, stewardship, surveillance, and governance are collectively strengthened. We contend that success will be determined less by laboratory and technology breakthroughs than by the political commitment to decouple revenue from sales volume and to govern antimicrobial effectiveness as a shared, exhaustible resource. We propose a coordinated policy toolkit \u2014 integrating \u201cpush-pull\u201d incentives and One Health surveillance \u2014 to protect the epidemiological utility of these finite resources. The antibiotics era began as a story of discovery, became a story of complacency, and must now become a story of stewardship and global governance.<\/jats:p>","DOI":"10.3389\/fpubh.2026.1965508","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:41:24Z","timestamp":1790833284000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From discovery to preparedness: reframing antimicrobial resistance as a global governance challenge"],"prefix":"10.3389","volume":"14","author":[{"given":"Quan Khoi","family":"Nguyen","sequence":"first","affiliation":[{"name":"College of Health Sciences, VinUniversity","place":["Hanoi, Vietnam"]},{"name":"Center for Innovations in Health Sciences, VinUniversity","place":["Hanoi, Vietnam"]},{"name":"Johns Hopkins Bloomberg School of Public Health, Baltimore","place":["MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Mayne","sequence":"additional","affiliation":[{"name":"College of Health Sciences, VinUniversity","place":["Hanoi, Vietnam"]},{"name":"Department of Medicine, University of California, Los Angeles, Los Angeles","place":["CA, United States"]},{"name":"Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia","place":["PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Taylor-Robinson","sequence":"additional","affiliation":[{"name":"College of Health Sciences, VinUniversity","place":["Hanoi, Vietnam"]},{"name":"Center for Innovations in Health Sciences, VinUniversity","place":["Hanoi, Vietnam"]},{"name":"Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia","place":["PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","first-page":"226","article-title":"On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenza","volume":"10","author":"Fleming","year":"1929","journal-title":"Br J Exp Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/82_2016_499","article-title":"History of antibiotics research","volume":"398","author":"Mohr","year":"2016","journal-title":"Curr Top Microbiol Immunol."},{"key":"B3","volume-title":"The Antibiotic Era: Reform, Resistance, and the Pursuit of a Rational Therapeutics.","author":"Podolsky","year":"2015"},{"key":"B4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-1-0716-3072-3_15","article-title":"Tracking antibiotic resistance from the environment to human health","volume":"2649","author":"Abdelrazik","year":"2023","journal-title":"Methods Mol Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fmicb.2010.00134","article-title":"A brief history of the antibiotic era: lessons learned and challenges for the future","volume":"1","author":"Aminov","year":"2010","journal-title":"Front Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1021\/acs.biochem.5c00044","article-title":"Molecular evolution and origins of antibiotic resistance genes","volume":"64","author":"Gholipour","year":"2025","journal-title":"Biochemistry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2471\/BLT.15.152710","article-title":"An international legal framework to address antimicrobial resistance","volume":"93","author":"Hoffman","year":"2015","journal-title":"Bull World Health Organ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41579-019-0293-3","article-title":"Antibiotic development \u2014 economic, regulatory and societal challenges","volume":"18","author":"\u00c5rdal","year":"2020","journal-title":"Nat Rev Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"GBD","year":"2024","journal-title":"Lancet"},{"key":"B10","unstructured":"MICROBE\n              interactive visualization tool\n            \n          \n          Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: a worldwide challenge","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial","year":"2022","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"816943","DOI":"10.3389\/fpubh.2022.816943","article-title":"System mapping of antimicrobial resistance to combat a rising global health crisis","volume":"10","author":"Matthiessen","year":"2022","journal-title":"Front Public Health."},{"key":"B14","doi-asserted-by":"publisher","first-page":"eabo7793","DOI":"10.1126\/scitranslmed.abo7793","article-title":"The past, present, and future of antibiotics","volume":"14","author":"Cook","year":"2022","journal-title":"Sci Transl Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1377\/hlthaff.2014.1003","article-title":"Repairing the broken market for antibiotic innovation","volume":"34","author":"Outterson","year":"2015","journal-title":"Health Aff."},{"key":"B16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/ja.2015.98","article-title":"A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics","volume":"69","author":"Renwick","year":"2016","journal-title":"J Antibiot."},{"key":"B17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.mib.2003.08.003","article-title":"Why is big Pharma getting out of antibacterial drug discovery?","volume":"6","author":"Projan","year":"2003","journal-title":"Curr Opin Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s44259-025-00123-1","article-title":"Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria","volume":"3","author":"Gargate","year":"2025","journal-title":"NJP Antimicrob Resist."},{"key":"B19","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1473-3099(22)00796-4","article-title":"Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries","volume":"23","author":"Patel","year":"2023","journal-title":"Lancet Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jgar.2019.05.024","article-title":"Global economic impact of antibiotic resistance: a review","volume":"19","author":"Ahmad","year":"2019","journal-title":"J Glob Antimicrob Resist."},{"key":"B21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1473-3099(25)00406-2","article-title":"Global policy responses to antimicrobial resistance, 2021-22: a systematic governance analysis of 161 countries and territories","volume":"26","author":"Patel","year":"2026","journal-title":"Lancet Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1093\/cid\/ciaa153","article-title":"Financing pull mechanisms for antibiotic-related innovation: opportunities for Europe","volume":"71","author":"\u00c5rdal","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41586-023-06887-8","article-title":"Discovery of a structural class of antibiotics with explainable deep learning","volume":"626","author":"Wong","year":"2024","journal-title":"Nature."},{"key":"B25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s42256-024-00809-7","article-title":"Generative AI for designing and validating easily synthesizable and structurally novel antibiotics","volume":"6","author":"Swanson","year":"2024","journal-title":"Nat Mach Intell."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1371\/journal.pmed.0030029","article-title":"Do we need to put society first? The potential for tragedy in antimicrobial resistance","volume":"3","author":"Foster","year":"2006","journal-title":"PLoS Med."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511807763","volume-title":"Governing the commons: The evolution of institutions for collective action","author":"Ostrom","year":"1990"},{"key":"B28","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.lanwpc.2020.100084","article-title":"An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach","volume":"7","author":"Chua","year":"2021","journal-title":"Lancet Reg Health West Pac."},{"key":"B29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","article-title":"21st WHO expert committee on selection and use of essential medicines. Classifying antibiotics in the WHO Essential Medicines List for optimal use \u2014 be AWaRe","volume":"18","author":"Sharland","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2105\/AJPH.2021.306695","article-title":"Governing global antimicrobial resistance: 6 key lessons from the Paris Climate Agreement","volume":"112","author":"Weldon","year":"2022","journal-title":"Am J Public Health."},{"key":"B31","unstructured":"Geneva\n          World Health Organization\n          World leaders commit to decisive action on antimicrobial resistance.\n          \n          2024"},{"key":"B32","doi-asserted-by":"publisher","first-page":"100558","DOI":"10.1016\/j.ijregi.2024.100558","article-title":"Antimicrobial resistance burden estimates from the bottom-up: research priorities for estimating the impact of antimicrobial resistance in Brazil","volume":"14","author":"Keenan","year":"2025","journal-title":"IJID Reg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e633","DOI":"10.1016\/S2214-109X(16)30142-5","article-title":"Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial","volume":"4","author":"Do","year":"2016","journal-title":"Lancet Glob Health."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S1473-3099(23)00125-1","article-title":"Implementation of point-of-care testing of C-reactive protein concentrations to improve antibiotic targeting in respiratory illness in Vietnamese primary care: a pragmatic cluster-randomised controlled trial","volume":"23","author":"Do","year":"2023","journal-title":"Lancet Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/S0140-6736(24)00862-6","article-title":"Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis","volume":"403","author":"Lewnard","year":"2024","journal-title":"Lancet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0140-6736(15)00547-4","article-title":"Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries","volume":"387","author":"Mendelson","year":"2016","journal-title":"Lancet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aao1495","article-title":"Reducing antimicrobial use in food animals","volume":"357","author":"Van Boeckel","year":"2017","journal-title":"Science."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0001305","DOI":"10.1371\/journal.pgph.0001305","article-title":"Global trends in antimicrobial use in food-producing animals:2020 to 2030","volume":"3","author":"Mulchandani","year":"2023","journal-title":"PLoS Glob Public Health."},{"key":"B39","doi-asserted-by":"publisher","first-page":"104895","DOI":"10.1016\/j.idnow.2024.104895","article-title":"Environment, animals, and food as reservoirs of antibiotic-resistant bacteria for humans: one health or more?","volume":"54","author":"Martak","year":"2024","journal-title":"Infect Dis Now."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1056\/NEJMp1311479","article-title":"Preserving antibiotics, rationally","volume":"369","author":"Hollis","year":"2013","journal-title":"N Engl J Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0140-6736(22)00087-3","article-title":"The overlooked pandemic of antimicrobial resistance","volume":"399","author":"Laxminarayan","year":"2022","journal-title":"Lancet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drup.2011.02.002","article-title":"Diagnostics as essential tools for containing antibacterial resistance","volume":"14","author":"Okeke","year":"2011","journal-title":"Drug Resist Updat."},{"key":"B43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jgar.2021.08.001","article-title":"Environmental antimicrobial resistance and its drivers: a potential threat to public health","volume":"27","author":"Samreen","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e000378","DOI":"10.1136\/bmjgh-2017-000378","article-title":"Mapping global policy discourse on antimicrobial resistance","volume":"2","author":"Wernli","year":"2017","journal-title":"BMJ Glob Health."},{"key":"B45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/jlme.12275","article-title":"Addressing antibiotic resistance requires robust international accountability mechanisms","volume":"3","author":"Hoffman","year":"2015","journal-title":"J Law Med Ethics"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1965508\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:41:28Z","timestamp":1790833288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1965508\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":45,"alternative-id":["10.3389\/fpubh.2026.1965508"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1965508","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1965508"}}